Biotherapeutics require extensive characterization and quality control (QC) testing prior to product release. These tests are resource intensive, time-consuming, and require updating as manufacturing ...
New Peptide MAM (multi-attribute method) workflow for the BioAccord LC-MS System monitors product quality attributes that can affect efficacy and safety of innovator drugs and biosimilars. End-to-end ...
Reliable identification of the physician–patient relationship is necessary for accurate evaluation. Standardization of evidence-based attribution methods is essential to improve the value of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results